Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 1
2010 1
2011 1
2012 2
2014 1
2015 2
2017 1
2019 1
2020 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Shifting the Immune-Suppressive to Predominant Immune-Stimulatory Radiation Effects by SBRT-PArtial Tumor Irradiation Targeting HYpoxic Segment (SBRT-PATHY).
Tubin S, Gupta S, Grusch M, Popper HH, Brcic L, Ashdown ML, Khleif SN, Peter-Vörösmarty B, Hyden M, Negrini S, Fossati P, Hug E. Tubin S, et al. Among authors: peter vorosmarty b. Cancers (Basel). 2020 Dec 26;13(1):50. doi: 10.3390/cancers13010050. Cancers (Basel). 2020. PMID: 33375357 Free PMC article. Review.
The Potential Contribution of Hexavalent Chromium to the Carcinogenicity of Chrysotile Asbestos.
Walter M, Schenkeveld WDC, Tomatis M, Schelch K, Peter-Vörösmarty B, Geroldinger G, Gille L, Bruzzoniti MC, Turci F, Kraemer SM, Grusch M. Walter M, et al. Among authors: peter vorosmarty b. Chem Res Toxicol. 2022 Dec 19;35(12):2335-2347. doi: 10.1021/acs.chemrestox.2c00314. Epub 2022 Nov 21. Chem Res Toxicol. 2022. PMID: 36410050 Free PMC article.
Lobatin B inhibits NPM/ALK and NF-κB attenuating anaplastic-large-cell-lymphomagenesis and lymphendothelial tumour intravasation.
Kiss I, Unger C, Huu CN, Atanasov AG, Kramer N, Chatruphonprasert W, Brenner S, McKinnon R, Peschel A, Vasas A, Lajter I, Kain R, Saiko P, Szekeres T, Kenner L, Hassler MR, Diaz R, Frisch R, Dirsch VM, Jäger W, de Martin R, Bochkov VN, Passreiter CM, Peter-Vörösmarty B, Mader RM, Grusch M, Dolznig H, Kopp B, Zupko I, Hohmann J, Krupitza G. Kiss I, et al. Among authors: peter vorosmarty b. Cancer Lett. 2015 Jan 28;356(2 Pt B):994-1006. doi: 10.1016/j.canlet.2014.11.019. Epub 2014 Nov 15. Cancer Lett. 2015. PMID: 25444930
FGF5 is expressed in melanoma and enhances malignancy in vitro and in vivo.
Ghassemi S, Vejdovszky K, Sahin E, Ratzinger L, Schelch K, Mohr T, Peter-Vörösmarty B, Brankovic J, Lackner A, Leopoldi A, Meindl D, Pirker C, Hegedus B, Marian B, Holzmann K, Grasl-Kraupp B, Heffeter P, Berger W, Grusch M. Ghassemi S, et al. Among authors: peter vorosmarty b. Oncotarget. 2017 Sep 23;8(50):87750-87762. doi: 10.18632/oncotarget.21184. eCollection 2017 Oct 20. Oncotarget. 2017. PMID: 29152117 Free PMC article.
Deregulation of the activin/follistatin system in hepatocarcinogenesis.
Grusch M, Drucker C, Peter-Vörösmarty B, Erlach N, Lackner A, Losert A, Macheiner D, Schneider WJ, Hermann M, Groome NP, Parzefall W, Berger W, Grasl-Kraupp B, Schulte-Hermann R. Grusch M, et al. Among authors: peter vorosmarty b. J Hepatol. 2006 Nov;45(5):673-80. doi: 10.1016/j.jhep.2006.06.014. Epub 2006 Jul 28. J Hepatol. 2006. PMID: 16935389
Expression of FGFR1-4 in Malignant Pleural Mesothelioma Tissue and Corresponding Cell Lines and its Relationship to Patient Survival and FGFR Inhibitor Sensitivity.
Vlacic G, Hoda MA, Klikovits T, Sinn K, Gschwandtner E, Mohorcic K, Schelch K, Pirker C, Peter-Vörösmarty B, Brankovic J, Dome B, Laszlo V, Cufer T, Rozman A, Klepetko W, Grasl-Kraupp B, Hegedus B, Berger W, Kern I, Grusch M. Vlacic G, et al. Among authors: peter vorosmarty b. Cells. 2019 Sep 16;8(9):1091. doi: 10.3390/cells8091091. Cells. 2019. PMID: 31527449 Free PMC article.
Fibroblast growth factor receptors as therapeutic targets in human melanoma: synergism with BRAF inhibition.
Metzner T, Bedeir A, Held G, Peter-Vörösmarty B, Ghassemi S, Heinzle C, Spiegl-Kreinecker S, Marian B, Holzmann K, Grasl-Kraupp B, Pirker C, Micksche M, Berger W, Heffeter P, Grusch M. Metzner T, et al. Among authors: peter vorosmarty b. J Invest Dermatol. 2011 Oct;131(10):2087-95. doi: 10.1038/jid.2011.177. Epub 2011 Jul 14. J Invest Dermatol. 2011. PMID: 21753785 Free PMC article.
The major vault protein mediates resistance to epidermal growth factor receptor inhibition in human hepatoma cells.
Losert A, Lötsch D, Lackner A, Koppensteiner H, Peter-Vörösmarty B, Steiner E, Holzmann K, Grunt T, Schmid K, Marian B, Grasl-Kraupp B, Schulte-Hermann R, Krupitza G, Berger W, Grusch M. Losert A, et al. Among authors: peter vorosmarty b. Cancer Lett. 2012 Jun 28;319(2):164-172. doi: 10.1016/j.canlet.2012.01.002. Epub 2012 Jan 17. Cancer Lett. 2012. PMID: 22261339
Stable protein expression in mammalian cells using baculoviruses.
Lackner A, Kreidl E, Peter-Vörösmarty B, Spiegl-Kreinecker S, Berger W, Grusch M. Lackner A, et al. Among authors: peter vorosmarty b. Methods Mol Biol. 2012;801:75-92. doi: 10.1007/978-1-61779-352-3_6. Methods Mol Biol. 2012. PMID: 21987248
The germacranolide sesquiterpene lactone neurolenin B of the medicinal plant Neurolaena lobata (L.) R.Br. ex Cass inhibits NPM/ALK-driven cell expansion and NF-κB-driven tumour intravasation.
Unger C, Kiss I, Vasas A, Lajter I, Kramer N, Atanasov AG, Nguyen CH, Chatuphonprasert W, Brenner S, Krieger S, McKinnon R, Peschel A, Kain R, Saiko P, Szekeres T, Kenner L, Hassler MR, Diaz R, Frisch R, Dirsch VM, Jäger W, de Martin R, Bochkov VN, Passreiter CM, Peter-Vörösmarty B, Mader RM, Grusch M, Dolznig H, Kopp B, Zupko I, Hohmann J, Krupitza G. Unger C, et al. Among authors: peter vorosmarty b. Phytomedicine. 2015 Aug 15;22(9):862-74. doi: 10.1016/j.phymed.2015.06.003. Epub 2015 Jun 26. Phytomedicine. 2015. PMID: 26220634
12 results